@article{article, title = {{Management of patients with germline predisposition to haematological malignancies considered for allogeneic blood and marrow transplantation: Best practice consensus guidelines from the UK Cancer Genetics Group (UKCGG), CanGene-CanVar, NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group and the British Society of Blood and Marrow Transplantation and cellular therapy (BSBMTCT)}}, publisher = {{Wiley}}, url = {{}}, year = {{2023}}, month = {{2}}, author = {{Clark A and Thomas S and Hamblin A and Talley P and Kulasekararaj A and Grinfeld J and Speight B and Snape K and McVeigh TP and Snowden JA}}, doi = {{10.1111/bjh.18682}}, journal = {{British Journal of Haematology}}, note = {{Accessed on 2025/05/25}}}